Assessment of inappropriate antibiotic prescribing among general dentists in the United States by Durkin, M. et al.
This is a repository copy of Assessment of inappropriate antibiotic prescribing among 
general dentists in the United States.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/124836/
Version: Accepted Version
Article:
Durkin, M., Feng, Q., Warren, K. et al. (6 more authors) (2018) Assessment of 
inappropriate antibiotic prescribing among general dentists in the United States. Journal of 
the American Dental Association, 149 (5). pp. 372-381. ISSN 0002-8177 
https://doi.org/10.1016/j.adaj.2017.11.034
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 
(CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long 
as you credit the authors, but you can’t change the article in any way or use it commercially. More 
information and the full terms of the licence here: https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Michael J. Durkin                                                                                                 JADA manuscript JADA - 384-17 
 
Title: Assessment of Inappropriate Antibiotic Prescribing Among General Dentists in the 
United States 
Author(s): Michael J. Durkin MD MPH1, Qianxi Feng BS1,2, Kyle Warren BA1,3, Peter B. 
Lockhart DDS4, Martin H. Thornhill MBBS BDS PhD4,5, Kiraat D. Munshi PhD6, Rochelle 
R. Henderson PhD6, Kevin Hsueh MD1, Victoria J. Fraser MD1; for the CDC Prevention 
Epicenters 
Affiliations: 1Division of Infectious Diseases, Washington University in St. Louis; 2Brown 
School of Social Work and Public Health, Washington University in St. Louis; 3University 
of Missouri School of Medicine; 4Carolinas Medical Center; 5University of Sheffield; 
6Express Scripts Holding Company 
 
Corresponding Author: 
Michael J. Durkin MD, MPH 
Campus Box 8051  
4523 Clayton Avenue 
St. Louis, MO 63110-1093 
Phone (314) 454-8225 
Fax (314) 454-5392 
Email mdurkin@dom.wustl.edu 
 
Michael J. Durkin                                                                                                 JADA manuscript JADA - 384-17 
 
Coauthor contact information: 
Qianxi Feng BS - qianxi.feng@wustl.edu 
Kyle Warren BA - kfwdm3@health.missouri.edu  
Peter Lockhart DDS - Peter.Lockhart@carolinashealthcare.org 
Martin H. Thornhill MBBS BDS PhD - M.Thornhill@Sheffield.ac.uk 
Kiraat Munshi PhD - KDMunshi@express-scripts.com 
Rochelle Henderson PhD - RRHenderson@express-scripts.com 
Kevin Hsueh MD -  kevin.hsueh@wustl.edu 
Victoria Fraser MD ± vfraser@wustl.edu 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Michael J. Durkin                                                                                                 JADA manuscript JADA - 384-17 
 
Abstract: 
Background: The purpose of this study is to assess dental antibiotic prescribing trends 
over time, quantify the number and types of antibiotics dentists prescribe 
inappropriately, and estimate the excess healthcare costs of inappropriate antibiotic 
prescribing using a large cohort of general dentists in the United States (U.S.).. 
Methods: We used a quasi-Poisson regression model to analyze antibiotic 
prescriptions trends by general dentists between 1/1/2013 and 12/31/2015 using data 
from Express Scripts, a large pharmacy benefits manager. We evaluated antibiotic 
duration and appropriateness for general dentists. Appropriateness was evaluated by 
reviewing the antibiotic prescribed and the duration of the prescription. 
Results: Overall, the number and rate of antibiotic prescriptions prescribed by general 
dentists remained stable in our cohort. Over the three year study period, approximately 
14% of antibiotic prescriptions were deemed inappropriate based on the antibiotic 
prescribed, antibiotic treatment duration, or both indicators. The quasi-Poisson 
regression model, which adjusted for number of beneficiaries covered, revealed a small 
but statistically significant decrease in the monthly rate of inappropriate antibiotic 
prescriptions by 0.32% (95% CI: 0.14%- 0.50%; p=0.001).  
Conclusions: Overall antibiotic prescribing practices among general dentists in this 
cohort remained stable over time. The rate of inappropriate antibiotic prescriptions by 
general dentists decreased slightly over time. 
Practical Implications: Based on these DXWKRUV¶GHILQLWLRn of appropriate antibiotic 
prescription choice and duration, inappropriate antibiotic prescriptions are common 
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(14% of all antibiotic prescriptions) among general dentists. Further analyses using 
chart review, administrative datasets, or other approaches are needed to better 
evaluate antibiotic prescribing practices among dentists. 
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Background 
Since the first use of penicillin in 1942,1 antibiotics have become an essential tool in 
modern healthcare. Antibiotics have reduced morbidity and mortality from infections and 
have facilitated the advancement of surgical treatments, cancer care, transplantation 
and treatment of many other diseases. The Centers for Disease Control and Prevention 
(CDC) estimates that over 262 million antibiotics are prescribed in United States (US) 
outpatient settings annually.2  However, approximately 30-50% of antibiotic 
prescriptions are unnecessary.1,3  While antibiotics have been indispensable in treating 
bacterial infections, the misuse and overuse of antibiotics has serious negative 
consequences. Increased antibiotic use is associated with development of increasing 
antibiotic resistance,4,5 Clostridium difficile infections,6,7 adverse drug events, and 
additional healthcare costs.8  Antibiotic resistant infections account for 23,000 deaths 
and billions of dollars in excess spending in the US annually.1  
Several organizations have made efforts to improve antibiotic prescribing. In the mid-
1990s, the CDC spearheaded efforts to better characterize, monitor, and reduce the 
inappropriate use of antibiotics and antibiotic resistance.  6SHFLILFDOO\WKH&'&¶V Get 
Smart about Antibiotics campaign aims to reduce unnecessary antibiotic use in the 
outpatient and hospital settings,9 and provides clinical guidelines for antibiotic 
stewardship programs in multiple healthcare settings.10-12  Other healthcare 
stakeholders, such as The Pew Charitable Trusts and The Joint Commission (TJC), a 
US hospital accreditation agency, have also provided public commitments to improve 
antibiotic prescribing practices.13,14  The Centers for Medicare & Medicaid Services 
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antimicrobial stewardship programs in hospitals in line with the new standards of TJC.14  
Although these initiatives represent large efforts by the CDC and other organizations, 
most of the work has been aimed at improving antimicrobial stewardship programs 
directed towards physicians¶DQWLELRWLFSUHVFULELQJSDWWHUQV. 
Prescriptions by general dentists account for 10% of all antibiotic prescriptions in the 
US;2,15 however, compared to the literature on physicians, fewer publications have 
evaluated antibiotic prescribing practices amongdentists.16-20 Some of the available 
dental studies suggest that inappropriate (non-guideline adherent) antibiotic prescribing 
among dentists is present.16-18, 20  For example, Roberts et al. reported that dentists 
prescribed several antibiotic agents that have no dental indications.16  In addition,  in a 
survey of dentists regarding the American Heart Association recommendations for 
antibiotic prophylaxis prior to dental procedures, approximately 70% of dentists reported 
prescribing antibiotics for prophylaxis outside the American Heart Association 
guidelines.17  Furthermore, antibiotic prescribing may be increasing among dentists, 
according to one Canadian study.18 This is in contrast to some studies demonstrating 
declines in antibiotic prescribing rates among US physicians.21-23   
This study aims to evaluate longitudinal antibiotic prescribing trends among dentists, 
quantify the number of potentially inappropriate antibiotic prescriptions, and estimate the 
healthcare costs of inappropriate antibiotic prescriptions among a large cohort of 
patients prescribed antibiotics by dentists in the United States. 
 
Methods 
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We analyzed data on outpatient antibiotic prescriptions from January 1, 2013 through 
December 31, 2015. The data was obtained from Express Scripts Holding Company 
(ESHC), the largest independent prescription benefits manager in the United States. 
ESHC holds detailed prescription data for over 80 million American beneficiaries.  We 
extracted data on provider specialty, name of antibiotic, dose, and treatment duration 
GD\V¶VXSSO\IRULQGLYLGXDOVLQWKLVODUJHFRKRUWLQWKH8QLWHG6WDWHV86:HGHILQHG
the US as all 50 states and Washington, DC. Other non-state US territiories were 
excluded from our analysis. Provider specialty was obtained from the ESHC database 
which uses designations from the Centers for Medicare and Medicaid Services, in 
addition to a proprietary source. We also obtained data on total costs for antibiotics  and 
the number of beneficiaries in the database during the study period.  Costs examined in 
this study were calculated by adding the prescription drug plan costs and out-of-pocket 
patient costs. Plan costs included ingredient costs, taxes, dispensing fees and 
administrative fees and were not adjusted to exclude rebates. Prescriptions with missing 
claims and/or provider information were excluded. Topical antibiotics, systemic or 
topical antifungals, antiparasitics, and antivirals were also excluded. Antibiotics with the 
same active ingredient, but a different formulation (e.g., extended release tablets) were 
combined. Antimicrobials with antibacterial properties (e.g., methenamine) were 
included.  
We analyzed the count and cost of antibiotics prescribed by general dentists to 
individuals equal to or greater than 18 years of age. Individuals who were less than 18 
years old were specifically excluded to ensure an accurate estimation of antibiotic 
SUHVFULSWLRQGXUDWLRQGHILQHGDVGD\V¶VXSSO\ This was done to prevent possible errors 
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in antibiotic prescription duration estimates generated from pediatric weight-based 
antibiotic dosing. We then used antibiotic duration to categorize prescriptions into 3 
separate purpose categories: ³prophylaxis´, ³indeterminate´, and ³treatment´. Antibiotic 
SUHVFULSWLRQVIRUGD\RUOHVVZHUHGHILQHGDV³SURSK\OD[LV´DQWLELRWLFSUHVFULSWLRQVIRU
WRGD\VZHUHGHILQHGDV³LQGHWHUPLQDWH´DQGDQWLELRWLF prescriptions for 5 days or 
PRUHZDVGHILQHGDV³WUHDWPHQW´$QWLELRWLFSXUSRVH FODVVLILHGDV³SURSK\OD[LV´RU
³WUHDWPHQW´ZDVGHILQHGDV³appropriate´, whereas those classified as ³indeterminate´ 
were defined as ³inappropriate´. This designation was made by expert opinion, 
American Dental Association (ADA) website materials on antibiotic stewardship,24 and 
consensus of coauthors. Of note, with the exception of erythromycin (which our group 
thought was inappropriate), our definition of appropriate antibiotics was broader 
(included more antibiotics) than the one listed on the ADA website. We also evaluated 
appropriateness of antibiotic use based on antibiotic prescribed. Antibiotics without 
common, clear dental indications were deemed ³inappropULDWH´E\FRQVHnsus of 
coauthors (Supplemental Table).  
We summed the number of prescriptions and total drug costs by each purpose and 
appropriateness category. We also calculated the number of prescriptions and drug 
costs per 1,000 eligible beneficiaries for each category.  
To investigate antibiotic prescribing trends over time, a quasi-Poisson regression model 
using calendar month as the independent variable was used; p-values of <0.05 were 
considered statistically significant. We evaluated trends of inappropriate antibiotic 
prescribing by evaluating antibiotic prescribed (e.g., ciprofloxacin), antibiotic treatment 
duration (e.g., 2-4 days supply), and inappropriate prescriptions that met either criterion. 
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7KHQXPEHURISUHVFULSWLRQVIRU³WUHDWPHQW´³LQGHWHUPLQDWH´DQG³SURSK\OD[LV´ZHUH
VXPPHGWRJHQHUDWHWKH³RYHUDOO´FDWHJRU\$OODQDO\VHVZHUHSHUIRUPHGusing the 
statistical software package R (v3.3.1). This study was approved by the Washington 
University in St. Louis Human Research Protection Office. 
Results 
Antibiotic uses and costs overall 
Approximately 6.2 million antibiotic prescriptions were identified over the three year 
study period (Table 1). While the overall number of antibiotic prescriptions remained 
stable each year, the overall antibiotic costs declined during our study period from 
around 19 million dollars in 2013 to a little more than 15 million dollars in 2015. After 
adjusting for the number of beneficiaries, the overall cost of antibiotics also declined 
from 614 dollars per 1,000 beneficiaries in 2013 to roughly 512 dollars per 1,000 
beneficiaries in 2015. 
Inappropriate antibiotic use and costs by antibiotic treatment duration 
(prescription durations that could not be categorized into either prophylaxis or 
treatment of dental infections based on prescribed duration). 
Over 12% of antibiotic prescriptions and 6% of total antibiotic costs were inappropriate 
due to being prescribed for an indeterminate duration (2-4 days; Table 1). This duration 
of antibiotics is too long for prophylaxis and shorter than appropriate for most treatment 
of dental infections. Over the three-year study period, this represents over 3 million 
dollars in inappropriate prescriptions based on duration alone.  
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Inappropriate antibiotic use and costs by antibiotic prescribed (agents that 
should not be routinely used in general dentistry).  
Over the three year study period, there were approximately 100,000 (1.63%) 
inappropriate antibiotic prescriptions based on antibiotic prescribed out of 6,228,948 
total prescriptions in this cohort (Table 2). The overall number of inappropriate 
antibiotics based on agent prescribed decreased from 38,424 (1.84% of total) 
prescriptions in 2013 to 28,516 prescriptions in 2015 (1.38% of total) (Table 3). In total, 
inappropriate antibiotic prescriptions by agent prescribed accounted for approximately 5 
million dollars (10.36% of total) in drug costs during the three year study period. 
Interestingly, despite the decreasing number of inappropriate antibiotic prescriptions by 
agent prescribed annually, the annual inappropriate antibiotic costs by agent prescribed 
increased by 24.71% from 1.5 million dollars in 2013 to 2.0 million dollars in 2015. 
Total burden of inappropriate antibiotic prescriptions. 
Taking into account inappropriate prescriptions based on both treatment duration and  
agent prescribed, Over 850,000 (13.70%) antibiotics were prescribed inappropriately 
during the three year study period.  The total number of inappropriate antibiotics 
prescribed decreased over time from 296,329 (14.23%) prescriptions in 2013 to 
269,419 (13.04%) prescriptions in 2015 (Table 3). In total, these inappropriate antibiotic 
prescriptions represent over 8 million dollars (15.86%) in unnecessary healthcare 
expenditures within this cohort. The annual inappropriate antibiotic spending increased 
from 2.6 million dollars in 2013 to 2.8 million dollars in 2015.  
Trends in antibiotic use. 
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From January 2013 to December 2015, the quasi-Poisson regression model 
demonstrated that overall rate of antibiotics prescribed per 1,000 beneficiaries remained 
stable (p=0.701; Figure 1). Similar results were observed for antibiotics used for 
treatment purposes (p=0.210; Figure 1). However, the rate of antibiotics prescribed for 
an indeterminate duration decreased by 0.21% per month (95% CI: 0.03%-0.40%; 
p=0.033); the rate of antibiotics prescribed for prophylaxis decreased by 0.50% per 
month (95% CI: 0.28%-0.72%; p< 0.001) (Figure 1).   
When using a quasi-Poisson regression model to evaluate  the rate of inappropriate 
antibiotic prescriptions per 1,000 beneficiaries by antibiotic agent prescribed, there were 
additional noteworthy trends. Appropriate antibiotic use overall remained stable over 
time (p=0.526; data not shown). However, the rate of inappropriate antibiotic prescribing 
(based on agent prescribed) declined by 1.14% per month (95% CI: 0.98-1.31%; 
p<0.001; Figure 2).   
When a quasi-Poisson regression model was used to evaluate antibiotic prescriptions 
by both treatment duration and agent prescribed, the rate of appropriate antibiotic 
prescribing remained stable over time (p= 0.278; data not shown). However, general 
dentists prescribed significantly fewer inappropriate drugs over time by 0.31% per 
month (95% CI: 0.14%-0.49%; p=0.002; Figure 3).  
Discussion 
To our knowledge, this study is the first and largest longitudinal evaluation of antibiotic 
prescribing practices of general dentists in a large cohort in the United States. This 
study is the first to quantify the amount of inappropriate antibiotics prescribed by general 
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dentists in the US and to estimate the cost of inappropriately prescribed antibiotics. 
Although the rate of antibiotic prescribing in this cohort was stable over time, there was 
a slight decrease in antibiotics used for indeterminate and prophylaxis purposes. 
Antibiotic expeditures did decrease over time. However, this was likely related to cost 
containment strageties (e.g effective purchase contracts and more utilization of 
generics) from the pharmacy benefits manager. Inappropriate antibiotic use based on 
agent prescribed and duration was common and contributed to millions of dollars in 
unnecessary prescription expenditures annually.  
The results of this study are in contrast to findings from some other countries. Marra et 
al. reported a concerning trend of increasing antibiotic prescribing by Canadian dentists 
from 1996-2013,19 and longitudinal studies of dental prescribing practices in Australia25 
and the Czech Republic26 also showed increasing trends in dental antibiotic prescribing.   
Reports from dentists cite numerous reasons for prescribing antibiotic.  Themes 
identified in a survey of Canadian dentists include antibiotic use when surgery is 
indicated, slow adoption of new prophylaxis guidelines, and an aging patient population, 
among others.19 A British study that investigated patient behaviors and dental visit 
characteristics associated with antibiotic prescriptions found that patients requesting 
DQWLELRWLFVDQGUHIXVLQJVXUJHU\DQGGHQWLVWV¶GHVLUH to save time led to more antibiotic 
prescriptions.27  $QRWKHUVWXG\LQWKH8QLWHG.LQJGRPQRWHGWKDWGHQWLVWV¶WHQGHQFLHVWR
prescribe antibiotics cannot be predicted by their gender, postgraduate qualification 
status, or years since qualification, indicating that antibiotic over-prescribing is likely a 
widespread problem across dental providers.28  
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While dental prescribing rates have remained unchanged overall, dentists appear to be 
prescribing fewer antibiotics for prophylaxis. Some of this improvement may be related 
to the 2007 American Heart Association (AHA) guidelines, which restricted the number 
of appropriate categories for endocarditis prophylaxis.29  However, more recent 
guidelines may also be playing a role. In 2014, the ADA Council on Scientific Affairs 
altered previous guidelines by recommending that antibiotic prophylaxis not be used 
prior to dental procedures for patients with prosthetic joints, although it is entirely 
unclear to what extent this has impacted the use of antibiotics for this purpose.30  There 
are likely many opportunities for continued improvement.   
Other than guidelines on the use of antibiotic prophylaxis for patients with prosthetic 
joints or at risk of infective endocarditis, there are ADA guidelines that comprehensively 
cover antibiotic usage.  One publication in 2004 from the ADA Council on Scientific 
Affairs31 provides general recommendations, but these do not explicitly endorse the use 
of specific antibiotics for certain types of infections.  There are no recommendations for 
duration of treatment in any of these guidelines. The American Academy of Pediatric 
Dentistry, however, has more specific guidelines for pediatric dental patients that 
include recommendations for a variety of orofacial conditions.32,33  
Other countries have established dental guidelines for antibiotic use.  In 2016, The 
Scottish Dental Clinical Effectiveness Programme (SDCEP) published its third iteration 
of prescription guidelines for dentists.34  This publication contains guidelines for a 
variety of dental and oral infections and specifies first-line versus second-line antibiotic 
medication choices and appropriate doses and durations.34 The Canadian Collaboration 
on Clinical Practice Guidelines in Dentistry has also published guidelines for treating 
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conditions like acute apical periodontitis and abscess.35 Clearly, detailed treatment 
guidelines for US dentists are necessary to improve and standardize antibiotic 
prescribing. 
Identifying evidence-based guideline recommendations may be challenging. The 
Cochrane Oral Health Group has attempted to develop dental antibiotic 
recommendations based on systematic review/meta-analysis for irreversible pulpitis, 
apical periodontitis and acute apical abscess.36,37  The lack of randomized clinical trials 
investigating antibiotic use in the scope of these conditions prevented the authors from 
drawing definitive conclusions.36,37 
Several antimicrobial stewardship interventions have demonstrated success in 
improving antibiotic utilization among dentists. In a 2001 study of 175 general dentists in 
the United Kingdom, researchers demonstrated a 42.5% decrease in antibiotic 
prescriptions after an educational intervention in which guidelines were issued.18 In a 
follow-up qualitative study describing the experiences of dentists who took part in the 
audit, over 97% of participating dentists stated the audit was useful and almost 70% of 
dentists reported changing their prescribing practices as a result of the audit.38 Other 
investigators have studied the audit and feedback intervention with similarly 
encouraging results.20,39  However, further investigation is needed to determine if these 
initial positive results are maintained long-term.  
Further research is needed to more completely characterize dental antibiotic prescribing 
trends in the US.  Specifically, qualitative investigations on dentistV¶ rationale for 
antibiotic selection and prescription duration are needed to truly evaluate their 
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appropriateness.  Such insights could  result in the successful development and 
implementation of more effectively targeted interventions.  Additionally, longer study 
periods are needed to further evaluate trends over time and more completely assess 
the effects of updated prophylaxis guidelines. 
Our study has limitations.  Individuals analyzed in our study were limited to patients 
within the ESHC database, so our results may not be generalizable to the entire US 
population. Additionally, the ESHC database only includes prescriptions which were 
SDLGIRUE\DSDWLHQW¶VLQVXUDQFHSODQ&KHDSer prescriptions, which may be less likely to 
prompt patients to use insurance benefits, may result in an underestimation of antibiotic 
prescription rates. Our classifications for appropriateness were fairly narrow and based 
on expert opinion and limited available US-based guidelines. Although we believe that 
the antibiotic agents prescribed and treatment durations we classified as inappropriate 
represent inappropriate antibiotics, this was an assumption in our calculations. Some of 
the indeterminate antibiotic prescriptions may be appropriately prescribed. For example, 
providers may elect to treat a patient with antibiotics until they could be seen by a 
dentist for an extraction or other another definitive procedure. Similarly, dentists may 
prescribe a two day supply of antibiotics for individuals who may require several dental 
procedures in the near future. In addition, our prescriptions were classified by treatment 
duration based on data from ESHC, so some atypical doses or instructions on the 
prescription bottle could have caused some antibiotic prescriptions to be misclassified. 
Unfortunately since the ESHC database did not contain indications for the antibiotic 
prescriptions, we were unable to fully assess the magnitude of inappropriate antibiotic 
prescribing among US general dentists in our cohort.  
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Conclusions 
We demonstrated that the overall rate of antibiotic prescriptions among general dentists 
has remained stable over time. In contrast to studies from other countries, we observed 
decreasing rates of inappropriate antibiotic prescriptions based on agent prescribed and 
treatment duration. Nonetheless, inappropriate antibiotic prescriptions based on 
antibiotic type and treatment duration were common (14%) in our study and represented 
millions of dollars in inappropriate pharmaceutical healthcare expenditures annually. 
Further interventions are necessary to improve antibiotic prescribing practices among 
general dentists. Antimicrobial stewardship programs specifically targeted to dentists 
should be implemented and evaluated. 
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Figure 3. Trend in inappropriate antibiotic prescriptions by antibiotic prescribed (if agent should not be routinely used in general dentistry) and treatment duration (prescription duration is not 
consistent with prophylaxis or treatment of dental infection) per 1,000 beneficiaries, within the Express Scripts database, January 2013 to December 2015.
Note: ŶƚŝďŝŽƚŝĐƉƌĞƐĐƌŝƉƚŝŽŶƐǁŝƚŚĂŶ ?ŝŶĚĞƚĞƌŵŝŶĂƚĞ ? ?-4 day treatment duration were defined as inappropriate because they could not be categorized as prophylaxis or treatment. Detailed 
appropriateness designations are available in supplemental table. Trend lines were generated using quasi-Poisson regression model.
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Table 1. Assessment of ŐĞŶĞƌĂůĚĞŶƚŝƐƚƐ ?ĂŶƚŝďŝŽƚŝĐƉƌĞƐĐƌŝďŝŶŐďǇƚƌĞĂƚŵĞŶƚĚƵƌĂƚŝŽŶ ?ǁŝƚŚŝŶƚŚĞǆƉƌĞƐƐ
Scripts database, January 2013 to December 2015.  
Year Duration No. of 
Prescriptions 
(millions)  
Prescriptions/1,000 
beneficiaries 
(%) 
Total Drug 
Costs ($) 
 
Costs per 1,000 
beneficiaries ($) 
2013 Overall 2.08 68.10  18,762,360 613.71 
Treatment 1.71 55.86 (82) 17,350,229 567.52 
Indeterminate 
(Inappropriate) 
0.26 8.53 (13) 1,119,868 36.63 
Prophylaxis 0.11 3.71 (5) 292,263 9.56 
2014 Overall 2.08 66.50 16,595,615 530.24 
Treatment 1.72 54.92 (83) 15,345,196 490.29 
Indeterminate 
(Inappropriate) 
0.26 8.21 (12) 996,651 31.84 
Prophylaxis 0.11 3.38 (5) 253,768 8.11 
2015 Overall 2.07 69.160 15,294,704 512.09 
Treatment 1.73 57.74 (83) 14,166,070 474.30 
Indeterminate 
(Inappropriate) 
0.24 8.14 (12) 912,755 30.56 
Prophylaxis 0.10 3.28 (5) 215,879 7.23 
EŽƚĞ ? ?WƌŽƉŚǇůĂǆŝƐ ?ǁĂƐĚĞĨŝŶĞĚĂƐ ?ĚĂǇƐ ?ƐƵƉƉůǇŽĨĂŶƚŝďŝŽƚŝĐƐŽƌĨĞǁĞƌ ? ?/ŶĚĞƚĞƌŵŝŶĂƚĞ ?ǁĂƐĚĞĨŝŶĞĚ
ĂƐ ?ƚŽ ?ĚĂǇƐ ?ƐƵƉƉůǇŽĨĂŶƚŝďŝŽƚŝĐƐ ? ?dƌĞĂƚŵĞŶƚ ?ǁĂƐĚĞĨŝŶĞĚĂƐ ?ŽƌŵŽƌĞĚĂǇƐ ?ƐƵƉƉůǇŽĨĂŶƚŝďŝŽƚŝĐƐ ?
ŶƚŝďŝŽƚŝĐƉƌĞƐĐƌŝƉƚŝŽŶƐǁŝƚŚĂŶ ?/ŶĚĞƚĞƌŵŝŶĂƚĞ ?ǁĞƌĞĚĞĨŝŶĞĚĂƐŝŶĂƉƉƌŽƉƌŝĂƚĞďĞĐĂƵƐĞƚŚĞǇĐŽƵůĚŶŽƚ
be categorized as prophylaxis or treatment. Costs examined in this study were calculated by adding the 
prescription drug plan costs and out-of-pocket patient costs. Plan costs included ingredient costs, taxes, 
dispensing fees and administrative fees and were not adjusted to exclude rebates. 
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Table 2. Antibiotic prescriptions among general dentists stratified by appropriateness of antibiotic 
prescribed (if the antibiotic is routinely used in general dentistry), within the Express Scripts database, 
January 2013 to December 2015.  
Year Appropriateness No. of 
Prescriptions 
(millions)  
Prescriptions/1,000 
beneficiaries 
(%) 
Total Drug 
Costs ($) 
Costs per 
1,000 
beneficiaries 
($) 
2013 Appropriate 2.04 66.84 (98) 17,245,993 564.11 
Inappropriate 0.04 1.25 (2) 1,516,367  49.60 
2014 Appropriate 2.05 65.44 (98) 14,878,372 475.38 
Inappropriate 0.03 1.06 (2) 1,717,242  54.87 
2015 Appropriate 2.04 68.20 (98) 13,280,603 444.66 
Inappropriate 0.03 0.95 (2) 2,014,101  67.44 
Total Appropriate 6.13 66.83 (98) 45,404,968 494.72 
Inappropriate 0.10 1.09 (2) 5,247,710  57.30 
Note. Detailed appropriateness designations are available in supplemental table. Costs examined in this 
study were calculated by adding the prescription drug plan costs and out-of-pocket patient costs. Plan 
costs included ingredient costs, taxes, dispensing fees and administrative fees and were not adjusted to 
exclude rebates. 
 
 
 
 
 
 
 
 
 
Michael J. Durkin                                                                                                 JADA manuscript JADA - 384-17 
 
Table 3. Antibiotic prescribing by general dentists stratified by appropriateness of antibiotic prescribed 
(if agent should be routinely used in general dentistry) and treatment duration (prescription duration is 
for either prophylaxis or treatment of an infection), within the Express Scripts database, January 2013- 
December 2015.  
Year Appropriateness No. of 
Prescriptions 
(millions)  
Prescriptions/1,000 
beneficiaries 
(%) 
Total Drug 
Costs ($) 
Costs per 1,000 
beneficiaries ($) 
2013 Appropriate 1.79 58.41 (86) 16,192,050  529.64 
Inappropriate 0.30 9.69 (14) 2,570,309  84.07 
2014 Appropriate 1.79 57.31 (86) 13,957,298  445.95 
Inappropriate 0.29 9.19 (14) 2,638,316  84.30 
2015 Appropriate 1.80 60.14 (87) 12,472,193  417.59 
Inappropriate 0.27 9.02 (13) 2,822,511  94.50 
Total Appropriate 5.38 58.62 (86) 42,621,541  464.39 
Inappropriate 0.85 9.30 (14) 8,031,137  87.62 
Note. Costs examined in this study were calculated by adding the prescription drug plan costs and out-
of-pocket patient costs. Plan costs included ingredient costs, taxes, dispensing fees and administrative 
fees and were not adjusted to exclude rebates. ƉƉƌŽƉƌŝĂƚĞĂŶƚŝďŝŽƚŝĐĚƵƌĂƚŝŽŶĂƐĚĞĨŝŶĞĚĂƐA䜀  ?ĚĂǇŽĨ 
ĂŶƚŝďŝŽƚŝĐƚƌĞĂƚŵĞŶƚŽƌA? ?ĚĂǇƐŽĨĂŶƚŝďŝŽƚŝĐƐ ?ůŝƐƚŽĨŝŶĂƉƉƌŽ ƌŝĂƚĞĂŶƚŝďŝŽƚŝĐƐďĂƐĞĚŽŶĂŐĞŶƚ
prescribed can be found in the supplemental materials. 
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Supplemental Table. Appropriateness designation of antibiotics prescribed by general dentists within 
the Express Scripts database, January 2013  ? December 2015. 
Inappropriate Appropriate 
Amikacin Cefepime Ciprofloxacin Fosfomycin Neomycin Sulfadiazine Amoxicillin Clindamycin 
Atovaquone Cefixime Clarithromycin Gemifloxacin Nitazoxanide Telithromycin Amoxicillin/ 
clavulanate 
Dicloxacillin 
Aztreonam Cefpodoxime Colistin Gentamicin Nitrofuranto
in 
Tinidazole Ampicillin Doxycycline 
Cefaclor Cefprozil Dapsone Imipenem/ 
cilastatin 
Norfloxacin Tobramycin Azithromycin Metronidazole 
Cefadroxil Ceftazidime Demeclocycline Levofloxacin Ofloxacin Trimethprim Cefadroxil Minocycline 
Cefazolin Ceftibuten Ertapenem Linezolid Paromomyci
n 
Trimethoprim
/ 
Sulfamethoxa
zole 
Ceftriaxone Penicillin G 
Cefdinir Ceftriaxone Erythromycin Methenamine Piperacillin/ 
tazobactam 
Vancomycin Cephalexin Penicillin VK 
Cefditoren Cefuroxime Fidaxomicin Moxifloxacin Rifaximin  Clarithromyci
n 
Tetracycline 
Note. The following sentences describe author rationale for some specific designations. Dapsone, 
demeclocycline, methenamine, neomycin, nitazoxanide, paromomycin, and sulfadiazine are infrequently 
used for common bacterial infections. However each agent has activity against bacteria and would be 
considered outside of standard dental practice. Select agents with intravenous formulations only 
(penicillin G, ceftriaxone, and cefazolin) were included as appropriate therapeutic options for individuals 
who were unable to tolerate oral antibiotics in the outpatient setting. All tetracycline antibiotics 
(tetracycline, minocycline, and doxycycline) were considered appropriate therapeutic options in our 
study due to similar tolerability and side effect profile. However, erythromycin was considered an 
inferior therapy to other macrolides due to side effect profile, and thus inappropriate; telithromycin was 
considered inappropriate because it is not listed as a therapeutic option in the ADA prophylaxis 
guidelines. Cefadroxil, a first generation cephalosporin, was considered an acceptable alternative to 
cephalexin.  Ceftriaxone was considered acceptable as it is listed in the ADA dental prophylaxis 
guidelines. However, other higher generation cephalosporin were considered too broad for routine 
general dental practice. 
 
